128 related articles for article (PubMed ID: 27805827)
1. Nrf2 activation as a key event triggered by skin sensitisers: The development of the stable KeratinoSens reporter gene assay.
Natsch A; Emter R
Altern Lab Anim; 2016 Oct; 44(5):443-451. PubMed ID: 27805827
[TBL] [Abstract][Full Text] [Related]
2. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro.
Emter R; Ellis G; Natsch A
Toxicol Appl Pharmacol; 2010 Jun; 245(3):281-90. PubMed ID: 20307559
[TBL] [Abstract][Full Text] [Related]
3. Intra- and inter-laboratory reproducibility and accuracy of the LuSens assay: A reporter gene-cell line to detect keratinocyte activation by skin sensitizers.
Ramirez T; Stein N; Aumann A; Remus T; Edwards A; Norman KG; Ryan C; Bader JE; Fehr M; Burleson F; Foertsch L; Wang X; Gerberick F; Beilstein P; Hoffmann S; Mehling A; van Ravenzwaay B; Landsiedel R
Toxicol In Vitro; 2016 Apr; 32():278-86. PubMed ID: 26796489
[TBL] [Abstract][Full Text] [Related]
4. A novel three-dimensional Nrf2 reporter epidermis model for skin sensitization assessment.
Brandmair K; Dising D; Finkelmeier D; Schepky A; Kuehnl J; Ebmeyer J; Burger-Kentischer A
Toxicology; 2024 Mar; 503():153743. PubMed ID: 38341018
[TBL] [Abstract][Full Text] [Related]
5. The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment.
Gerberick GF
Altern Lab Anim; 2016 Oct; 44(5):437-442. PubMed ID: 27805826
[TBL] [Abstract][Full Text] [Related]
6. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
[TBL] [Abstract][Full Text] [Related]
7. Performance of the N/TERT epidermal model for skin sensitizer identification via Nrf2-Keap1-ARE pathway activation.
Alloul-Ramdhani M; Tensen CP; El Ghalbzouri A
Toxicol In Vitro; 2014 Aug; 28(5):982-9. PubMed ID: 24794257
[TBL] [Abstract][Full Text] [Related]
8. Gene expression changes induced by skin sensitizers in the KeratinoSens™ cell line: Discriminating Nrf2-dependent and Nrf2-independent events.
Emter R; van der Veen JW; Adamson G; Ezendam J; van Loveren H; Natsch A
Toxicol In Vitro; 2013 Dec; 27(8):2225-32. PubMed ID: 24055896
[TBL] [Abstract][Full Text] [Related]
9. The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories.
Andreas N; Caroline B; Leslie F; Frank G; Kimberly N; Allison H; Heather I; Robert L; Stefan O; Hendrik R; Andreas S; Roger E
Toxicol In Vitro; 2011 Apr; 25(3):733-44. PubMed ID: 21195160
[TBL] [Abstract][Full Text] [Related]
10. Development of novel in vitro photosafety assays focused on the Keap1-Nrf2-ARE pathway.
Tsujita-Inoue K; Hirota M; Atobe T; Ashikaga T; Tokura Y; Kouzuki H
J Appl Toxicol; 2016 Jul; 36(7):956-68. PubMed ID: 26511905
[TBL] [Abstract][Full Text] [Related]
11. Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.
Basketter D; Alépée N; Casati S; Crozier J; Eigler D; Griem P; Hubesch B; de Knecht J; Landsiedel R; Louekari K; Manou I; Maxwell G; Mehling A; Netzeva T; Petry T; Rossi LH
Regul Toxicol Pharmacol; 2013 Dec; 67(3):531-5. PubMed ID: 24140884
[TBL] [Abstract][Full Text] [Related]
12. Classification of chemicals as sensitisers based on new test methods.
Botham PA
Toxicol Lett; 1992 Dec; 64-65 Spec No():165-71. PubMed ID: 1471170
[TBL] [Abstract][Full Text] [Related]
13. Structure--activity relationship between the in vivo skin sensitizing potency of analogues of phenyl glycidyl ether and the induction of Nrf2-dependent luciferase activity in the KeratinoSens in vitro assay.
Delaine T; Niklasson IB; Emter R; Luthman K; Karlberg AT; Natsch A
Chem Res Toxicol; 2011 Aug; 24(8):1312-8. PubMed ID: 21751775
[TBL] [Abstract][Full Text] [Related]
14. Reporter cell lines for skin sensitization testing.
Natsch A; Emter R
Arch Toxicol; 2015 Oct; 89(10):1645-68. PubMed ID: 26194644
[TBL] [Abstract][Full Text] [Related]
15. Devising a Tier-based Skin Sensitisation Screening Strategy for Personal Care and Cosmetic Products.
Fung ES; Towle KM; Monnot AD
Altern Lab Anim; 2020 Mar; 48(2):70-77. PubMed ID: 32441989
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA).
Ashikaga T; Sakaguchi H; Sono S; Kosaka N; Ishikawa M; Nukada Y; Miyazawa M; Ito Y; Nishiyama N; Itagaki H
Altern Lab Anim; 2010 Aug; 38(4):275-84. PubMed ID: 20822320
[TBL] [Abstract][Full Text] [Related]
17. The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers--functional relevance and a hypothesis on innate reactions to skin sensitizers.
Natsch A
Toxicol Sci; 2010 Feb; 113(2):284-92. PubMed ID: 19767620
[TBL] [Abstract][Full Text] [Related]
18. A fast Resazurin-based live viability assay is equivalent to the MTT-test in the KeratinoSens assay.
Emter R; Natsch A
Toxicol In Vitro; 2015 Jun; 29(4):688-93. PubMed ID: 25687527
[TBL] [Abstract][Full Text] [Related]
19. Identification of gene expression markers and development of evaluation method using cell-based and RT-PCR-based assay for skin sensitising potential of chemicals.
Nishikawa MU; Iwaki M; Tashiro K; Kurose K
Xenobiotica; 2020 Nov; 50(11):1359-1369. PubMed ID: 32394774
[TBL] [Abstract][Full Text] [Related]
20. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.
Ezendam J; Braakhuis HM; Vandebriel RJ
Arch Toxicol; 2016 Dec; 90(12):2861-2883. PubMed ID: 27629427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
